ATE376827T1 - Solid darreichungsform enthaltend koffein - Google Patents

Solid darreichungsform enthaltend koffein

Info

Publication number
ATE376827T1
ATE376827T1 AT04255750T AT04255750T ATE376827T1 AT E376827 T1 ATE376827 T1 AT E376827T1 AT 04255750 T AT04255750 T AT 04255750T AT 04255750 T AT04255750 T AT 04255750T AT E376827 T1 ATE376827 T1 AT E376827T1
Authority
AT
Austria
Prior art keywords
solid pharmaceutical
caffeine
form containing
pharmaceutical form
containing caffeine
Prior art date
Application number
AT04255750T
Other languages
English (en)
Inventor
Indukumar G Shah
Christopher E Szymczak
Anthony A Osei
Karl J Pruss
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE376827T1 publication Critical patent/ATE376827T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04255750T 2003-09-23 2004-09-22 Solid darreichungsform enthaltend koffein ATE376827T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/671,138 US20050065172A1 (en) 2003-09-23 2003-09-23 Solid dosage form comprising caffeine

Publications (1)

Publication Number Publication Date
ATE376827T1 true ATE376827T1 (de) 2007-11-15

Family

ID=34194840

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04255750T ATE376827T1 (de) 2003-09-23 2004-09-22 Solid darreichungsform enthaltend koffein

Country Status (11)

Country Link
US (1) US20050065172A1 (de)
EP (1) EP1518551B1 (de)
KR (1) KR20050030157A (de)
CN (1) CN100441224C (de)
AT (1) ATE376827T1 (de)
CA (1) CA2482114C (de)
DE (1) DE602004009731T2 (de)
ES (1) ES2295787T3 (de)
MX (1) MXPA04009258A (de)
PL (1) PL1518551T3 (de)
PT (1) PT1518551E (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525029D0 (en) * 2005-12-08 2006-01-18 Univ Hull Receptor Antagonist
US20150209360A1 (en) * 2014-01-30 2015-07-30 Orbz, Llc Oral caffeine delivery composition
US20210274828A1 (en) * 2014-06-06 2021-09-09 Nicholas J. Singer Quick dissolve drinks and edibles and machine for manufacturing the same

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1287431A (en) * 1969-04-16 1972-08-31 Aspro Nicholas Ltd Improvements in pharmaceutical formulations
US4049803A (en) * 1976-04-26 1977-09-20 Bristol-Myers Company Augmentation of blood levels of aspirin
US4486436A (en) * 1982-07-22 1984-12-04 Analgesic Associates Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
US4420483A (en) * 1982-07-22 1983-12-13 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising ibuprofen and methods of using same
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
US4943565A (en) * 1986-09-15 1990-07-24 Bristol-Myers Squibb Company Analgesic tablet of aspirin and caffeine containing low-substituted hydroxypropyl cellulose
ES2120451T7 (es) * 1991-09-06 2009-11-05 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Composicion que comprende un compuesto de tramadol y acetaminofeno, y su uso.
ES2046097B1 (es) * 1991-10-28 1994-09-01 S A L V A T Lab Sa Procedimiento para preparar una composicion antidesmenorrea.
US5409709A (en) * 1991-11-29 1995-04-25 Lion Corporation Antipyretic analgesic preparation containing ibuprofen
US6020002A (en) * 1994-06-14 2000-02-01 Fuisz Technologies Ltd. Delivery of controlled-release system(s)
US5958453A (en) * 1996-10-31 1999-09-28 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility
AU5822798A (en) * 1998-01-13 1999-08-02 Procter & Gamble Company, The A detergent granule with improved dissolution
GB9816899D0 (en) * 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
DE19931708A1 (de) * 1999-07-08 2001-01-18 Bayer Ag Verfahren zur Herstellung schnell zerfallender, fester pharmazeutischer Zubereitungen

Also Published As

Publication number Publication date
DE602004009731D1 (de) 2007-12-13
EP1518551B1 (de) 2007-10-31
CN100441224C (zh) 2008-12-10
MXPA04009258A (es) 2005-07-05
PT1518551E (pt) 2007-12-06
KR20050030157A (ko) 2005-03-29
ES2295787T3 (es) 2008-04-16
CA2482114A1 (en) 2005-03-23
EP1518551A1 (de) 2005-03-30
DE602004009731T2 (de) 2008-08-28
CN1616103A (zh) 2005-05-18
PL1518551T3 (pl) 2008-03-31
US20050065172A1 (en) 2005-03-24
CA2482114C (en) 2011-12-13

Similar Documents

Publication Publication Date Title
ATE350013T1 (de) Nanopartikelzusammensetzungen enthaltend insulin
UY38044A (es) Composiciones farmacéuticas sólidas que comprenden fenofibrato en nanopartículas
ES2191616T3 (es) Polvos pulverizables de fluoropolimeros no fibrilables.
WO2003024396A3 (en) Dry powder medicament formulations
ATE332126T1 (de) Geschmacksmaskierte pharmazeutische zusammensetzungen
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
NZ548351A (en) Direct compression formulation and process
BR0311585A (pt) Sistema de fornecimento de drogas, método para administrar uma droga oftálmica a um paciente, kit, uso do mesmo, método para preparar o sistema de fornecimento de drogas, e, artigo de fabricação
WO2006085101A3 (en) Pharmaceutical compositions useful in the transmucosal administration of drugs
WO2004019999A3 (en) Agent delivery particle
CY1107714T1 (el) Φαρμακευτικες συνθεσεις μοδαφινιλιου
DE60234945D1 (de) Pulver zur nasalen verabreichung von wirkstoffen
DK1196146T3 (da) Pulverpartikler med glat overflade til anvendelse i inhalationsterapi
DE69706988T2 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
AU2003304237A8 (en) Gel-stabilized nanoparticulate active agent compositions
BR0213608A (pt) Composição oral
IL169793A (en) Compounds containing antacids and antioxidants and using them for the preparation of a medicinal product
CA2535013A1 (en) Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
WO2006041843A3 (en) Pharmaceutical dosage form comprising meloxicam
DE69907717D1 (de) Pharmazeutische formulierung in form eines trockenen pulvers
DE60044245D1 (de) Herstellungsverfahren von ultrafeinen zinkoxidteilchen
ATE376827T1 (de) Solid darreichungsform enthaltend koffein
MXPA05003442A (es) Composicion antitranspirante de tipo emulsion de aceite en agua que contiene microparticulas de cera.
MY121175A (en) Ciclesonide-containing aqueous pharmaceutical composition
BR0006736A (pt) Processo para aperfeiçoar a estabilidade de pelo menos um derivado de dibenzoilmetano diante da radiação uv e utilização de um filtro uv orgânico insolúvel sob a forma micronizada

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties